Recent Advances in Anti-Infective Drug Discovery

Scopus Cite Score: 2.2

Indexed in: Scopus, MEDLINE/PubMed, Cabell's Directory/Journalytics

View All
Aims and Scope:
Recent Advances in Anti-Infective Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. The journal is essential reading for all researchers involved in anti-infective drug design and discovery. The journal also covers recent research in fast emerging therapeutic areas/targets & therapeutic agents related to anti-infective drug discovery. All aspects related to viral or bacterial diseases including HIV, AIDS and other sexually transmitted diseases (STDs) are also included in the scope of the journal.
Read more...
Start Submission Button Icon

Editor-in-Chief:

  • Tianhong Dai Massachusetts General Hospital
    Harvard Medical School
    Boston, MA
    United States of America

ISSN: 2772-4344 (Print)

eISSN: 2772-4352 (Online)

Special Issues With Active Call for Papers

Submission closes on: Nov 14, 2026
HIV/AIDS: Research Gaps in Developing Countries

HIV care in developing countries has achieved significant milestones, with many people now surviving beyond two decades on therapy. Studying the determinants of such long-term success provides invaluable lessons. Yet, persistent challenges remain: gaps in drug resistance surveillance, limited viral load access, delayed treatment switches, and inadequate opportunistic infection data. Vulnerable groups—children, adolescents, pregnant women, key populations, and older adults—remain underrepresented in research. Of particular concern is the rising threat of HIV-associated antimicrobial resistance (AMR).... see more

Guest Editor(s): Dr. Prasan Panda
Co-Guest Editor(s): Dr. Binod Pati
Start Submission
Submission closes on: Jul 19, 2026
Pharmacological Advances in the Diagnosis, Prevention, and Treatment of Tuberculosis.

Tuberculosis (TB) remains a major global health challenge, exacerbated by the emergence of multidrug-resistant strains and co-infections with HIV. This thematic issue aims to highlight current advances and innovations in the diagnosis, prevention, and treatment of TB, with a special emphasis on translational and pharmacological research. Contributions will cover molecular diagnostics, biomarkers, host-directed therapies, novel anti-mycobacterial agents, vaccine development, and strategies to overcome drug resistance. By bringing together original research, reviews, and expert perspectives, this... see more

Guest Editor(s): Dr. Wenping Gong
Co-Guest Editor(s): Dr. Syed Luqman Ali
Start Submission